AAAAAA

   
Results: 1-6 |
Results: 6
Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents
Authors: Zisterer, DM McGee, MM Campiani, G Ramunno, A Fattorusso, C Nacci, V Lawler, M Williams, DC
Citation: Dm. Zisterer et al., Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents, BIOCH SOC T, 29, 2001, pp. 704-706
Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor Bcr-Abl
Authors: Mc Gee, MM Campiani, G Ramunno, A Fattorusso, C Nacci, V Lawler, M Williams, DC Zisterer, DM
Citation: Mm. Mc Gee et al., Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor Bcr-Abl, J PHARM EXP, 296(1), 2001, pp. 31-40
Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent
Authors: Campiani, G Aiello, F Fabbrini, M Morelli, E Ramunno, A Armaroli, S Nacci, V Garofalo, A Greco, G Novellino, E Maga, G Spadari, S Bergamini, A Ventura, L Bongiovanni, B Capozzi, M Bolacchi, F Marini, S Coletta, M Guiso, G Caccia, S
Citation: G. Campiani et al., Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent, J MED CHEM, 44(3), 2001, pp. 305-315
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). New glutamate and aspartate analogues as potential neuroprotective agents
Authors: Campiani, G De Angelis, M Armaroli, S Fattorusso, C Catalanotti, B Ramunno, A Nacci, V Novellino, E Grewer, C Ionescu, D Rauen, T Griffiths, R Sinclair, C Fumagalli, E Mennini, T
Citation: G. Campiani et al., A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). New glutamate and aspartate analogues as potential neuroprotective agents, J MED CHEM, 44(16), 2001, pp. 2507-2510
The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464 - A novel generation of nonnucleoside inhibitors
Authors: Maga, G Ramunno, A Nacci, V Locatelli, GA Spadari, S Fiorini, I Baldanti, F Paolucci, S Zavattoni, M Bergamini, A Galletti, B Muck, S Hubscher, U Giorgi, G Guiso, G Caccia, S Campiani, G
Citation: G. Maga et al., The stereoselective targeting of a specific enzyme-substrate complex is the molecular mechanism for the synergic inhibition of HIV-1 reverse transcriptase by (R)-(-)-PPO464 - A novel generation of nonnucleoside inhibitors, J BIOL CHEM, 276(48), 2001, pp. 44653-44662
Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: Further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity
Authors: Campiani, G Morelli, E Fabbrini, M Nacci, V Greco, G Novellino, E Ramunno, A Maga, G Spadari, S Caliendo, G Bergamini, A Faggioli, E Uccella, I Bolacchi, F Marini, S Coletta, M Nacca, A Caccia, S
Citation: G. Campiani et al., Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: Further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity, J MED CHEM, 42(21), 1999, pp. 4462-4470
Risultati: 1-6 |